Category: Diseases & Conditions
Diseases & Conditions market research reports by DelveInsight
-
OCS-01 Emerging Drug Insight and Market Forecast − 2032
OCS-01 Emerging Drug Insight and Market Forecast − 2032 “OCS-01 Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about OCS-01 for acute ocular pain (AOP) in the eight major markets. A detailed picture of the OCS-01 for acute ocular pain in the 8MM, i.e., the U ... Read More
-
Metastatic Prostate Cancer - Market Insight, Epidemiology And Market Forecast - 2032
Metastatic Prostate Cancer - Market Insight, Epidemiology And Market Forecast - 2032 DelveInsight's ""Metastatic Prostate Cancer - Market Insights, Epidemiology, and Market Forecast-2032"" report delivers an in-depth understanding of the metastatic prostate cancer, historical and forecasted epidemio ... Read More
-
Metastatic HR+/HER2− Breast Cancer - Market Insights, Epidemiology, and Market Forecast-2032
Metastatic HR+/HER2− Breast Cancer - Market Insights, Epidemiology, and Market Forecast-2032 Key Highlights Breast cancer is a genetically and clinically heterogeneous disease with multiple subtypes. The HR+/HER2- subtype is the most common of all the breast cancer subtypes. The total market size in ... Read More
-
Non-metastatic Prostate Cancer (nmPC) - Market Insight, Epidemiology and Market Forecast -2032
Non-metastatic Prostate Cancer (nmPC) - Market Insight, Epidemiology and Market Forecast -2032 Key Highlights Non-metastatic prostate cancer (nmPC) refers to prostate cancer that has not spread beyond the prostate gland and nearby lymph nodes. It is a localized form of prostate cancer. When prostate ... Read More
-
Chronic Hepatitis B - Market Insight, Epidemiology And Market Forecast - 2032
Chronic Hepatitis B - Market Insight, Epidemiology And Market Forecast - 2032 Key Highlights People infected with Chronic Hepatitis B often have no symptoms, which may be the primary cause of the low diagnosis rate across the 7MM since many people go undiagnosed. In 2022, the market size of Chronic ... Read More
-
Postmenopausal osteoporosis - Pipeline Insight, 2023
Postmenopausal osteoporosis - Pipeline Insight, 2023 DelveInsight’s, “Postmenopausal osteoporosis - Pipeline Insight, 2023,” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Postmenopausal osteoporosis pipeline landscape. It covers the pipeline drug profiles, incl ... Read More
-
Triple Negative Breast Cancer Epidemiology Forecast - 2032
Triple Negative Breast Cancer Epidemiology Forecast - 2032 Key Highlights Breast cancer is a genetically and clinically heterogeneous disease with multiple subtypes. The classification of these subtypes has evolved over the years. The most common and widely accepted classification of breast cancer i ... Read More
-
Insulin Delivery Device - Global Market Insights, Competitive Landscape, and Market Forecast - 2028
Insulin Delivery Device - Global Market Insights, Competitive Landscape, and Market Forecast - 2028 Insulin Delivery Devices Market By Product Type (Insulin Syringes, Insulin Pens, Insulin Pumps [Tethered/External Pumps and Patch Pumps], Insulin Injectors, and Others), End-User (Homecare Settings, D ... Read More
-
Pain Management Devices - Global Market Insights, Competitive Landscape, and Market Forecast - 2028
Pain Management Devices - Global Market Insights, Competitive Landscape, and Market Forecast - 2028 Pain Management Devices Market By Type Of Devices (Neuromodulation and Neurostimulation Devices, Analgesic Infusion Pumps [Intrathecal Infusion Pumps and External Infusion Pumps], Ablation Devices [Ra ... Read More
-
Still’s Disease- Pipeline Insight, 2023
Still’s Disease- Pipeline Insight, 2023 DelveInsight’s, “Still’s Disease- Pipeline Insight, 2023” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Still’s Disease pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage pr ... Read More
-
Cutaneous T-Cell Lymphoma (CTCL)- Pipeline Insight, 2023
Cutaneous T-Cell Lymphoma (CTCL)- Pipeline Insight, 2023 DelveInsight’s, “Cutaneous T-Cell Lymphoma (CTCL)- Pipeline Insight, 2023” report provides comprehensive insights about 30+ companies and 35+ pipeline drugs in Cutaneous T-Cell Lymphoma pipeline landscape. It covers the pipeline drug profiles, ... Read More
-
Graves’ Disease- Pipeline Insight, 2023
Graves’ Disease- Pipeline Insight, 2023 DelveInsight’s, “Graves’ Disease- Pipeline Insight, 2023” report provides comprehensive insights about 8+ companies and 10+ pipeline drugs in Graves’ Disease pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage pro ... Read More
-
T cell Lymphoma -Pipeline Insight, 2023
T cell Lymphoma -Pipeline Insight, 2023 DelveInsight’s, “T-cell Lymphoma -Pipeline Insight, 2023” report provides comprehensive insights about 90+ companies and 90+ pipeline drugs in T-cell Lymphoma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage p ... Read More
-
Non Muscle Invasive Bladder Cancer- Pipeline Insight, 2023
Non Muscle Invasive Bladder Cancer- Pipeline Insight, 2023 DelveInsight’s, “Non Muscle Invasive Bladder Cancer- Pipeline Insight, 2023” report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in Non Muscle Invasive Bladder Cancer pipeline landscape. It covers the pipeline d ... Read More
-
Fibromyalgia- Pipeline Insight, 2023
Fibromyalgia- Pipeline Insight, 2023 DelveInsight’s, “Fibromyalgia- Pipeline Insight, 2023” report provides comprehensive insights about 10+ companies and 15+ pipeline drugs in Fibromyalgia pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. I ... Read More
-
Asthma - Market Insight, Epidemiology and Market Forecast -2032
Asthma - Market Insight, Epidemiology and Market Forecast -2032 DelveInsight's ""Asthma- Market Insights, Epidemiology, and Market Forecast-2032"" report delivers an in-depth understanding of the Asthma, historical and forecasted epidemiology as well as the Asthma market trends in the United States, ... Read More
-
Chemotherapy-induced peripheral neuropathy - Epidemiology Forecast - 2032
Chemotherapy-induced peripheral neuropathy - Epidemiology Forecast - 2032 Key Highlights Chemotherapy-induced peripheral neuropathy (CIPN) is a frequent, dose-dependent complication of anticancer drugs, including platinum, taxanes, epothilones, vinca alkaloids, and newer agents, such as bortezomib. ... Read More
-
Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS)-inhibitors – Market Insights, Epidemiology and Market Forecast – 2032
Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS)-inhibitors – Market Insights, Epidemiology and Market Forecast – 2032 Key Highlights: In Japan, the contribution of KRAS mutations is lower compared to Western countries like the United States and Europe In the United States, KRASG12C is present in ~ ... Read More
-
Triple Negative Breast Cancer - Pipeline Insight, 2023
Triple Negative Breast Cancer - Pipeline Insight, 2023 DelveInsight’s, “Triple Negative Breast Cancer - Pipeline Insight, 2023,” report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in Triple Negative Breast Cancer pipeline landscape. It covers the pipeline drug profiles ... Read More
-
Anal Cancer - Pipeline Insight, 2023
Anal Cancer - Pipeline Insight, 2023 DelveInsight’s, “Anal Cancer - Pipeline Insight, 2023” report provides comprehensive insights about 6+ companies and 8+ pipeline drugs in Anal Cancer pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It a ... Read More
-
Asthma- Pipeline Insight, 2023
Asthma- Pipeline Insight, 2023 DelveInsight’s, “Asthma- Pipeline Insight, 2023,” report provides comprehensive insights about 90+ companies and 100+ pipeline drugs in Asthma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers th ... Read More
-
Postoperative Pain- Pipeline Insight, 2023
Postoperative Pain- Pipeline Insight, 2023 DelveInsight’s, “Postoperative Pain- Pipeline Insight, 2023,” report provides comprehensive insights about 45+ companies and 50+ pipeline drugs in Postoperative Pain pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinica ... Read More
-
Sjogren’s syndrome- Pipeline Insight, 2023
Sjogren’s syndrome- Pipeline Insight, 2023 DelveInsight’s, “Sjogren’s syndrome- Pipeline Insight, 2023” report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in Sjogren’s syndrome pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical ... Read More
-
Ovarian Cancer- Pipeline Insight, 2023
Ovarian Cancer- Pipeline Insight, 2023 DelveInsight’s, “Ovarian Cancer- Pipeline Insight, 2023” report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in Ovarian Cancer pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage pro ... Read More
-
Hepatitis C Virus Infection- Pipeline Insight, 2023
Hepatitis C Virus Infection- Pipeline Insight, 2023 DelveInsight’s, “Hepatitis C Virus Infection- Pipeline Insight, 2023” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Hepatitis C Virus Infection pipeline landscape. It covers the pipeline drug profiles, includi ... Read More
Research Assistance
